Composition of Optomed’s Nomination Board - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Composition of Optomed’s Nomination Board

Optomed Plc Stock Exchange Release 12 September 2023 at 13:00, Helsinki

Composition of Optomed’s Nomination Board

The composition of Optomed’s Nomination Board will remain the same as last year. According to Optomed’s shareholder register of 1 September 2023, the shareholders represented in the shareholders’ Nomination Board are OP-Rahastoyhtiö Oy (OP funds), Aktia Rahastoyhtiö Oy (Aktia funds) and Finnish Industry Investment Ltd. These shareholders have appointed the following persons to the Nomination Board:

 

  • Vesa Vanha-Honko, OP funds
  • Markus Lindqvist, Aktia funds
  • Keith Bonnici, Finnish Industry Investment Ltd


Petri Salonen, Chairman of Optomed’s Board of Directors, will serve as the Nomination Board's expert member.

According to the resolution of Optomed General Meeting, the Optomed Nomination Board consists of the representatives of Optomed three largest shareholders as of the first trading day September, and the Chairman of the Board of Directors as an expert member. Should a shareholder not wish to exercise the nomination right, the right shall be transferred to the next largest shareholder who otherwise would not be entitled to nominate a member.

The Nomination Board is to prepare proposals on the composition and members of the Board of Directors and their remuneration for the next Annual General Meeting and it will submit its proposal to the Board of Directors 31 January 2024 at the latest.



Optomed Plc



Further enquiries

Petri Salonen, Chairman of the Board, Optomed Plc, [email protected]

Sakari Knuutti, CFO, Optomed Plc, [email protected]

 

 

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.

www.optomed.com

Nyheter om Optomed

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Optomed

Senaste nytt